Neuropace, Inc. (NPCE) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time NPCE price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 43.0 Neutral
Market Cap $499.4M
Volume 178.1K
Fundamentals — 10-Q Q2 2026
Revenue $44.8M
Net Income $-12.9M
EPS $-0.38
Gross Margin 82.4%
Operating Margin -24.0%
Net Margin -28.8%
Debt / Equity 5.0x
P/E Ratio -38.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Morrell Martha | CHIEF MEDICAL OFFICER | Sell | 25,000 | $15.97 | $399,250 | 2025 Dec 15 |
| OrbiMed Capital GP VI LLC | 10% Owner | Sell | 168,136 | $15.85 | $2.7M | 2025 May 14 |
| Morrell Martha | CHIEF MEDICAL OFFICER | Sell | 78,334 | $13.72 | $1.1M | 2025 Feb 21 |
| Kck Ltd. | 10% Owner | Sell | 5,270,845 | $9.40 | $49.5M | 2025 Feb 20 |
| Morrell Martha | CHIEF MEDICAL OFFICER | Sell | 300 | $15.00 | $4,500 | 2025 Jan 30 |
| Morrell Martha | CHIEF MEDICAL OFFICER | Sell | 3,200 | $15.01 | $48,032 | 2025 Jan 24 |
| Kck Ltd. | 10% Owner | Sell | 224,138 | $5.45 | $1.2M | 2024 Oct 25 |
| Kck Ltd. | 10% Owner | Sell | 4,082 | $6.09 | $24,859 | 2024 Oct 22 |
| Kck Ltd. | 10% Owner | Sell | 8,598 | $6.21 | $53,375 | 2024 Oct 21 |
| Kck Ltd. | 10% Owner | Sell | 46,426 | $6.54 | $303,445 | 2024 Oct 17 |
| Kck Ltd. | 10% Owner | Sell | 39,684 | $6.92 | $274,714 | 2024 Oct 2 |
| OrbiMed Capital GP VI LLC | 10% Owner | Sell | 29,206 | $14.02 | $409,426 | 2024 May 3 |
| OrbiMed Capital GP VI LLC | 10% Owner | Sell | 1,781 | $14.06 | $25,041 | 2024 Apr 24 |
| OrbiMed Capital GP VI LLC | 10% Owner | Sell | 64,653 | $14.12 | $913,057 | 2024 Apr 23 |
| Orbimed Advisors LLC | 10% Owner | Sell | 16,992 | $14.02 | $238,231 | 2024 Apr 18 |
| Orbimed Advisors LLC | 10% Owner | Sell | 485,000 | $14.49 | $7.0M | 2024 Apr 12 |
| Morrell Martha | Chief Medical Officer | Sell | 17,589 | $15.09 | $265,411 | 2024 Feb 5 |
| Morrell Martha | Chief Medical Officer | Sell | 13,848 | $15.09 | $209,027 | 2024 Feb 1 |
| Morrell Martha | Chief Medical Officer | Sell | 828 | $15.03 | $12,445 | 2024 Jan 25 |
| Morrell Martha | Chief Medical Officer | Sell | 13,402 | $10.12 | $135,616 | 2023 Dec 27 |
Take NPCE further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put NPCE in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Neuropace, Inc. next reports.
Set alerts on NPCE
Get notified when Neuropace, Inc. hits your price targets or technical conditions are met.
Get Started Free